Sign in

CIK 0001638097 · Non-accelerated filer<br>Smaller reporting company

Entera Bio Ltd.

Sign in to watch
Ticker
ENTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Israel
Entity type
operating
Phone
972-2-532-7151
Business address
KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR, JERUSALEM, Israel, 9112002
  1. 4 Grant or award Director acquired 18,061 shares (grant or award)
  2. 4 Grant or award Director acquired 23,172 shares (grant or award)
  3. 4 Grant or award Director acquired 27,261 shares (grant or award)
  4. SC 13G/A Stake Amended Statement of Ownership
  5. S-8 Other Securities Offered to Employees in Benefit Plans
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations · Regulation FD disclosure
  8. 8-K Event Shareholder vote results
  9. 4/A Grant or award Chief Financial Officer acquired 30,151 shares (grant or award)
  10. 4 Grant or award Chief Executive Officer acquired 124,121 shares (grant or award)
  11. DEFA14A Proxy Proxy Materials
  12. ARS Other Annual Report to Security Holders
  13. DEF 14A Proxy Proxy Statement
  14. 3 Insider Initial Statement of Ownership
  15. PRE 14A Proxy Proxy Statement (Preliminary)
  16. 10-Q Report Quarterly Report
  17. 8-K Event Results of operations · Regulation FD disclosure
  18. 4 Grant or award Chief Financial Officer acquired 30,151 shares (grant or award)
  19. 4 Grant or award Chief Operating Officer acquired 30,151 shares (grant or award)
  20. S-8 Other Securities Offered to Employees in Benefit Plans

Page 7 of 21 · 420 filings